Printer Friendly Version  View printer-friendly version
<< Back
Array CEO Robert E. Conway to Speak at the Third Annual Needham Biotechnology Conference

BOULDER, Colo., June 9 /PRNewswire-FirstCall/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the Needham Biotechnology Conference on June 17 in New York City. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.

     Event:      Third Annual Needham Biotechnology Conference
     Presenter:  Robert E. Conway, Chief Executive Officer, Array BioPharma
     Date:       Thursday, June 17, 2004
     Time:       10:00 a.m. Eastern Time
     Location:   The New York Palace Hotel, New York City

About Array BioPharma:

Array BioPharma is creating the next generation of orally active drugs by integrating the latest advances in chemistry, biology and informatics. Our drug development pipeline is focused primarily in cancer and inflammatory disease and includes several promising small molecule drugs that regulate targets in therapeutically important disease pathways. In addition, Array collaborates with leading pharmaceutical and biotechnology companies to design, create and optimize drug candidates across a broad range of therapeutic areas. Our mission is to be the most efficient inventor of high quality drug candidates in the pharmaceutical industry. For more information on Array, please go to

Array BioPharma Inc.



Tricia Haugeto of Array BioPharma Inc., +1-303-386-1193,

/Web site: / (ARRY)

ShareThis Copy and Paste